Piotr Zimniak
Concepts (531)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glutathione Transferase | 57 | 2016 | 178 | 5.530 |
Why?
| Aldehydes | 32 | 2015 | 97 | 3.980 |
Why?
| Longevity | 7 | 2012 | 87 | 1.730 |
Why?
| Lipid Peroxidation | 14 | 2016 | 132 | 1.680 |
Why?
| Isoenzymes | 24 | 2009 | 177 | 1.330 |
Why?
| Caenorhabditis elegans | 6 | 2011 | 146 | 1.260 |
Why?
| Carrier Proteins | 19 | 2004 | 359 | 1.030 |
Why?
| Glutathione | 32 | 2009 | 330 | 0.970 |
Why?
| Oxidative Stress | 14 | 2011 | 958 | 0.950 |
Why?
| Adenosine Triphosphatases | 22 | 2003 | 90 | 0.910 |
Why?
| Caenorhabditis elegans Proteins | 4 | 2011 | 60 | 0.840 |
Why?
| Animals | 68 | 2016 | 14385 | 0.680 |
Why?
| Bile Acids and Salts | 14 | 2002 | 76 | 0.660 |
Why?
| ATP-Binding Cassette Transporters | 11 | 2003 | 31 | 0.620 |
Why?
| Aging | 4 | 2011 | 784 | 0.570 |
Why?
| Adenosine Triphosphate | 17 | 2003 | 242 | 0.570 |
Why?
| Xenobiotics | 5 | 2003 | 27 | 0.570 |
Why?
| Liver | 18 | 2016 | 1225 | 0.570 |
Why?
| GTPase-Activating Proteins | 9 | 2003 | 23 | 0.480 |
Why?
| Fatty Acids | 3 | 2011 | 174 | 0.450 |
Why?
| Signal Transduction | 11 | 2011 | 1753 | 0.410 |
Why?
| Geriatrics | 1 | 2012 | 47 | 0.410 |
Why?
| Mice | 30 | 2016 | 6413 | 0.400 |
Why?
| Lithocholic Acid | 6 | 2003 | 13 | 0.390 |
Why?
| Doxorubicin | 12 | 2003 | 259 | 0.390 |
Why?
| Obesity | 2 | 2010 | 1202 | 0.370 |
Why?
| Cell Membrane | 15 | 2009 | 278 | 0.360 |
Why?
| Adipose Tissue | 2 | 2008 | 207 | 0.350 |
Why?
| Receptors, Muscarinic | 3 | 2003 | 18 | 0.350 |
Why?
| Substrate Specificity | 20 | 2004 | 209 | 0.340 |
Why?
| DNA | 3 | 2009 | 581 | 0.330 |
Why?
| Metabolic Detoxication, Phase I | 1 | 2008 | 11 | 0.330 |
Why?
| Kinetics | 28 | 2004 | 692 | 0.320 |
Why?
| Gene Expression | 4 | 2009 | 664 | 0.310 |
Why?
| Colonic Neoplasms | 3 | 2005 | 164 | 0.310 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 446 | 0.310 |
Why?
| Lipid Metabolism | 1 | 2008 | 194 | 0.310 |
Why?
| Growth Inhibitors | 2 | 2005 | 32 | 0.280 |
Why?
| Chief Cells, Gastric | 2 | 2003 | 3 | 0.280 |
Why?
| Anions | 3 | 1994 | 9 | 0.280 |
Why?
| Catalysis | 11 | 2009 | 98 | 0.270 |
Why?
| Cloning, Molecular | 4 | 2009 | 198 | 0.270 |
Why?
| Alleles | 9 | 2004 | 277 | 0.270 |
Why?
| Receptor, Insulin | 1 | 2005 | 44 | 0.270 |
Why?
| Liver Diseases, Alcoholic | 2 | 2015 | 35 | 0.260 |
Why?
| Leukemia L5178 | 1 | 2005 | 3 | 0.260 |
Why?
| Citric Acid | 3 | 2010 | 21 | 0.260 |
Why?
| Thymidine Kinase | 1 | 2005 | 20 | 0.260 |
Why?
| Erythrocytes | 5 | 2003 | 98 | 0.260 |
Why?
| Apoptosis | 8 | 2008 | 1300 | 0.250 |
Why?
| Mutagens | 1 | 2005 | 81 | 0.250 |
Why?
| Transfection | 10 | 2009 | 399 | 0.250 |
Why?
| Molecular Sequence Data | 11 | 2009 | 980 | 0.250 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2009 | 206 | 0.250 |
Why?
| Biological Transport | 14 | 2003 | 195 | 0.250 |
Why?
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 5 | 2004 | 12 | 0.240 |
Why?
| RNA Interference | 4 | 2011 | 195 | 0.240 |
Why?
| Base Sequence | 7 | 2011 | 719 | 0.240 |
Why?
| Rats | 23 | 2005 | 3415 | 0.230 |
Why?
| Carcinogens | 6 | 2001 | 231 | 0.230 |
Why?
| Microsomes, Liver | 7 | 1992 | 214 | 0.230 |
Why?
| Mutagenesis, Site-Directed | 8 | 2004 | 117 | 0.230 |
Why?
| Blotting, Western | 13 | 2016 | 683 | 0.230 |
Why?
| Recombinant Proteins | 10 | 2009 | 569 | 0.230 |
Why?
| Humans | 68 | 2012 | 54284 | 0.230 |
Why?
| Membrane Glycoproteins | 5 | 1994 | 269 | 0.220 |
Why?
| Binding Sites | 10 | 2004 | 440 | 0.210 |
Why?
| Taurine | 3 | 2002 | 16 | 0.210 |
Why?
| Water | 2 | 1999 | 102 | 0.200 |
Why?
| Glucuronates | 9 | 1992 | 21 | 0.200 |
Why?
| Chromatography, Affinity | 8 | 2009 | 50 | 0.200 |
Why?
| Drug Resistance, Neoplasm | 5 | 2003 | 309 | 0.200 |
Why?
| Biological Transport, Active | 12 | 2002 | 35 | 0.190 |
Why?
| Models, Molecular | 8 | 2004 | 423 | 0.180 |
Why?
| K562 Cells | 8 | 2009 | 47 | 0.180 |
Why?
| Acetyl-CoA Carboxylase | 2 | 2010 | 17 | 0.180 |
Why?
| Aconitate Hydratase | 2 | 2010 | 14 | 0.180 |
Why?
| Valine | 3 | 2000 | 54 | 0.180 |
Why?
| Carcinoembryonic Antigen | 1 | 1999 | 15 | 0.180 |
Why?
| Lipid Peroxides | 4 | 2008 | 15 | 0.170 |
Why?
| Cell Line | 7 | 2009 | 1153 | 0.170 |
Why?
| Malonyl Coenzyme A | 2 | 2008 | 9 | 0.170 |
Why?
| Amino Acid Sequence | 9 | 2009 | 767 | 0.160 |
Why?
| Reactive Oxygen Species | 3 | 2011 | 491 | 0.160 |
Why?
| PPAR alpha | 2 | 2016 | 64 | 0.160 |
Why?
| Cysteine Proteinase Inhibitors | 3 | 2009 | 28 | 0.160 |
Why?
| Isoleucine | 3 | 2004 | 25 | 0.150 |
Why?
| Structure-Activity Relationship | 6 | 2004 | 423 | 0.140 |
Why?
| Mice, Knockout | 6 | 2016 | 926 | 0.140 |
Why?
| Calcium | 3 | 1991 | 432 | 0.140 |
Why?
| Escherichia coli | 4 | 2009 | 250 | 0.140 |
Why?
| Lung | 3 | 1996 | 507 | 0.140 |
Why?
| Animals, Genetically Modified | 2 | 2005 | 52 | 0.140 |
Why?
| Hyperbilirubinemia | 2 | 1993 | 13 | 0.140 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 673 | 0.130 |
Why?
| Mitochondrial Proteins | 1 | 2015 | 121 | 0.130 |
Why?
| Bile | 3 | 1990 | 24 | 0.130 |
Why?
| Muscarinic Antagonists | 3 | 2003 | 18 | 0.130 |
Why?
| Chrysenes | 3 | 1998 | 3 | 0.120 |
Why?
| Antibiotics, Antineoplastic | 3 | 2003 | 85 | 0.120 |
Why?
| Carcinoma, Hepatocellular | 1 | 1997 | 203 | 0.120 |
Why?
| Genes | 1 | 1994 | 38 | 0.120 |
Why?
| Organic Anion Transporters, Sodium-Dependent | 1 | 1993 | 3 | 0.120 |
Why?
| Phospholipids | 5 | 2001 | 63 | 0.120 |
Why?
| Hydroxysteroid Dehydrogenases | 1 | 1993 | 4 | 0.120 |
Why?
| Protein Processing, Post-Translational | 3 | 2015 | 183 | 0.120 |
Why?
| Erythrocyte Membrane | 4 | 2001 | 15 | 0.120 |
Why?
| Symporters | 1 | 1993 | 18 | 0.120 |
Why?
| Hyperbilirubinemia, Hereditary | 1 | 1993 | 1 | 0.120 |
Why?
| Jaundice, Chronic Idiopathic | 1 | 1993 | 1 | 0.120 |
Why?
| Phosphorylation | 6 | 2009 | 614 | 0.120 |
Why?
| Crystallography, X-Ray | 5 | 2004 | 178 | 0.120 |
Why?
| Sodium | 1 | 1993 | 102 | 0.120 |
Why?
| Mutation | 4 | 2009 | 1501 | 0.110 |
Why?
| Lung Neoplasms | 4 | 2003 | 642 | 0.110 |
Why?
| Mice, Inbred C57BL | 2 | 2009 | 1999 | 0.110 |
Why?
| Mitogen-Activated Protein Kinases | 5 | 2004 | 169 | 0.110 |
Why?
| Steroids | 2 | 2004 | 53 | 0.110 |
Why?
| Polymerase Chain Reaction | 2 | 2016 | 531 | 0.110 |
Why?
| Liver Neoplasms | 1 | 1997 | 352 | 0.110 |
Why?
| Sequence Homology, Amino Acid | 4 | 2009 | 180 | 0.110 |
Why?
| Electrophoresis, Polyacrylamide Gel | 5 | 2002 | 124 | 0.110 |
Why?
| Liposomes | 6 | 2003 | 53 | 0.110 |
Why?
| CHO Cells | 5 | 2003 | 123 | 0.110 |
Why?
| Cricetinae | 5 | 2003 | 209 | 0.110 |
Why?
| Internationality | 1 | 2012 | 49 | 0.110 |
Why?
| Electrophoresis | 2 | 2009 | 18 | 0.110 |
Why?
| Carcinogens, Environmental | 2 | 2004 | 36 | 0.110 |
Why?
| Taurolithocholic Acid | 3 | 2002 | 4 | 0.100 |
Why?
| Ionophores | 1 | 1991 | 5 | 0.100 |
Why?
| Male | 20 | 2014 | 27334 | 0.100 |
Why?
| Wound Infection | 1 | 2011 | 31 | 0.100 |
Why?
| Cholic Acids | 2 | 1990 | 3 | 0.100 |
Why?
| Glutathione S-Transferase pi | 6 | 2000 | 20 | 0.100 |
Why?
| Peptide Fragments | 6 | 2009 | 242 | 0.100 |
Why?
| Stereoisomerism | 6 | 2004 | 106 | 0.100 |
Why?
| Dinitrochlorobenzene | 3 | 2001 | 4 | 0.100 |
Why?
| Amiloride | 1 | 1990 | 14 | 0.100 |
Why?
| Antineoplastic Agents | 4 | 2003 | 1300 | 0.100 |
Why?
| Bicarbonates | 1 | 1990 | 21 | 0.100 |
Why?
| Bacterial Infections | 1 | 2011 | 105 | 0.100 |
Why?
| Rats, Inbred Strains | 7 | 1992 | 172 | 0.090 |
Why?
| RNA, Messenger | 3 | 2014 | 1202 | 0.090 |
Why?
| Cholestasis | 1 | 1990 | 45 | 0.090 |
Why?
| Phenanthrenes | 2 | 2000 | 13 | 0.090 |
Why?
| Anion Transport Proteins | 3 | 1994 | 5 | 0.090 |
Why?
| Polycyclic Compounds | 2 | 2001 | 6 | 0.090 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 1991 | 192 | 0.090 |
Why?
| Lipids | 1 | 2011 | 178 | 0.090 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2009 | 59 | 0.090 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 208 | 0.090 |
Why?
| Burns | 1 | 2011 | 170 | 0.090 |
Why?
| Acetylcholine | 3 | 2003 | 53 | 0.090 |
Why?
| Bacterial Proteins | 2 | 2004 | 454 | 0.090 |
Why?
| Vimentin | 1 | 2009 | 33 | 0.090 |
Why?
| Oxidation-Reduction | 2 | 2008 | 382 | 0.090 |
Why?
| Aldehyde Dehydrogenase | 1 | 2008 | 27 | 0.090 |
Why?
| Amino Acid Substitution | 4 | 2004 | 105 | 0.080 |
Why?
| Recombinant Fusion Proteins | 3 | 2005 | 206 | 0.080 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 51 | 0.080 |
Why?
| Retinal Pigment Epithelium | 1 | 2008 | 24 | 0.080 |
Why?
| Disease Models, Animal | 4 | 2016 | 1639 | 0.080 |
Why?
| Proteolipids | 5 | 2003 | 9 | 0.080 |
Why?
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2007 | 4 | 0.080 |
Why?
| Fas Ligand Protein | 1 | 2007 | 21 | 0.080 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 46 | 0.080 |
Why?
| Glucose Tolerance Test | 1 | 2008 | 67 | 0.080 |
Why?
| Genotype | 1 | 2009 | 599 | 0.080 |
Why?
| Sarcoplasmic Reticulum | 3 | 1991 | 22 | 0.080 |
Why?
| Serotonin | 1 | 2009 | 159 | 0.080 |
Why?
| Models, Animal | 2 | 2005 | 255 | 0.080 |
Why?
| Tumor Cells, Cultured | 5 | 2003 | 477 | 0.080 |
Why?
| Enzyme Stability | 2 | 1999 | 27 | 0.080 |
Why?
| Cell Nucleus | 1 | 2007 | 203 | 0.070 |
Why?
| Cholinergic Agonists | 2 | 2003 | 17 | 0.070 |
Why?
| Cell Line, Transformed | 2 | 2004 | 88 | 0.070 |
Why?
| Homeostasis | 1 | 2008 | 223 | 0.070 |
Why?
| Cell Division | 4 | 2004 | 330 | 0.070 |
Why?
| Polymorphism, Genetic | 5 | 2000 | 193 | 0.070 |
Why?
| Molecular Weight | 4 | 1995 | 100 | 0.070 |
Why?
| Protein Kinase C | 3 | 1998 | 65 | 0.070 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2008 | 250 | 0.070 |
Why?
| Carcinoma, Non-Small-Cell Lung | 3 | 2003 | 164 | 0.070 |
Why?
| Antigens, CD | 1 | 2008 | 242 | 0.070 |
Why?
| Alanine | 3 | 2004 | 44 | 0.070 |
Why?
| Female | 12 | 2016 | 28441 | 0.070 |
Why?
| Neoplasm Proteins | 2 | 2003 | 359 | 0.070 |
Why?
| Promoter Regions, Genetic | 2 | 2005 | 520 | 0.070 |
Why?
| Carbon Tetrachloride | 1 | 2005 | 20 | 0.070 |
Why?
| Nuclear Proteins | 1 | 2007 | 252 | 0.070 |
Why?
| Cells, Cultured | 6 | 2009 | 1737 | 0.070 |
Why?
| Guinea Pigs | 2 | 2003 | 89 | 0.070 |
Why?
| Hot Temperature | 2 | 1999 | 199 | 0.070 |
Why?
| Receptors, Steroid | 1 | 2005 | 21 | 0.070 |
Why?
| Epithelium, Corneal | 1 | 2005 | 10 | 0.070 |
Why?
| DNA Primers | 3 | 2011 | 225 | 0.070 |
Why?
| Insulin Resistance | 1 | 2008 | 300 | 0.070 |
Why?
| Multidrug Resistance-Associated Proteins | 3 | 2001 | 19 | 0.070 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 85 | 0.070 |
Why?
| Muscle, Skeletal | 1 | 2011 | 847 | 0.070 |
Why?
| Transcription Factors | 2 | 2007 | 622 | 0.070 |
Why?
| Steroid Isomerases | 1 | 2004 | 1 | 0.070 |
Why?
| Forkhead Transcription Factors | 1 | 2005 | 118 | 0.060 |
Why?
| JNK Mitogen-Activated Protein Kinases | 4 | 2007 | 78 | 0.060 |
Why?
| Blood Glucose | 1 | 2008 | 489 | 0.060 |
Why?
| Peptide Mapping | 5 | 1996 | 22 | 0.060 |
Why?
| Phosphatidylcholines | 2 | 2001 | 33 | 0.060 |
Why?
| Stress, Psychological | 1 | 2006 | 270 | 0.060 |
Why?
| Subcellular Fractions | 2 | 2001 | 43 | 0.060 |
Why?
| Lactones | 1 | 2004 | 27 | 0.060 |
Why?
| Islets of Langerhans | 1 | 2004 | 23 | 0.060 |
Why?
| Oxidants | 2 | 2011 | 64 | 0.060 |
Why?
| Cell Transformation, Neoplastic | 1 | 2005 | 200 | 0.060 |
Why?
| Models, Biological | 4 | 2008 | 823 | 0.060 |
Why?
| Blotting, Southern | 1 | 2004 | 40 | 0.060 |
Why?
| Gene Library | 1 | 2004 | 50 | 0.060 |
Why?
| Arteriosclerosis | 1 | 2004 | 59 | 0.060 |
Why?
| Malondialdehyde | 1 | 2004 | 63 | 0.060 |
Why?
| Egtazic Acid | 1 | 2003 | 16 | 0.060 |
Why?
| Deoxycholic Acid | 2 | 2002 | 17 | 0.060 |
Why?
| Vinca Alkaloids | 1 | 2003 | 2 | 0.060 |
Why?
| Gene Deletion | 2 | 2015 | 293 | 0.060 |
Why?
| Glucuronosyltransferase | 4 | 1991 | 157 | 0.060 |
Why?
| Hydrogen Peroxide | 2 | 2011 | 142 | 0.060 |
Why?
| Gene Expression Regulation | 2 | 2006 | 1062 | 0.060 |
Why?
| Plasmids | 1 | 2004 | 180 | 0.060 |
Why?
| Genetic Vectors | 1 | 2004 | 139 | 0.060 |
Why?
| GTP-Binding Proteins | 1 | 2003 | 94 | 0.060 |
Why?
| Epoxy Compounds | 2 | 2000 | 48 | 0.060 |
Why?
| Azotobacter | 1 | 1983 | 1 | 0.060 |
Why?
| Tetrazolium Salts | 2 | 2003 | 17 | 0.060 |
Why?
| Protein Isoforms | 3 | 2015 | 124 | 0.060 |
Why?
| Thiotepa | 2 | 2000 | 5 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 368 | 0.060 |
Why?
| Rats, Mutant Strains | 2 | 1993 | 11 | 0.060 |
Why?
| Protein-Tyrosine Kinases | 1 | 2003 | 101 | 0.060 |
Why?
| Calcium-Binding Proteins | 1 | 1983 | 61 | 0.060 |
Why?
| Crystallization | 2 | 1999 | 46 | 0.060 |
Why?
| Acetylcholinesterase | 1 | 2002 | 21 | 0.060 |
Why?
| Arginine | 2 | 2001 | 182 | 0.060 |
Why?
| Thiazoles | 2 | 2003 | 61 | 0.060 |
Why?
| Antineoplastic Agents, Alkylating | 2 | 2000 | 74 | 0.050 |
Why?
| Binding, Competitive | 3 | 1998 | 113 | 0.050 |
Why?
| Colchicine | 2 | 2001 | 35 | 0.050 |
Why?
| Muscle, Smooth | 1 | 2002 | 68 | 0.050 |
Why?
| Down-Regulation | 3 | 2011 | 388 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 5 | 2007 | 1476 | 0.050 |
Why?
| Immunoglobulin G | 4 | 2003 | 226 | 0.050 |
Why?
| Chromatography, High Pressure Liquid | 6 | 1998 | 377 | 0.050 |
Why?
| Aorta, Thoracic | 1 | 2002 | 90 | 0.050 |
Why?
| Carcinoma, Small Cell | 4 | 2003 | 28 | 0.050 |
Why?
| Survival Analysis | 1 | 2004 | 735 | 0.050 |
Why?
| Protein Conformation | 2 | 1999 | 226 | 0.050 |
Why?
| Protein Binding | 2 | 2001 | 736 | 0.050 |
Why?
| Bone Density | 1 | 2004 | 416 | 0.050 |
Why?
| Drosophila melanogaster | 1 | 2001 | 24 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2001 | 42 | 0.050 |
Why?
| Body Composition | 1 | 2004 | 349 | 0.050 |
Why?
| Leucine | 2 | 1999 | 113 | 0.050 |
Why?
| Chlorambucil | 1 | 2000 | 6 | 0.050 |
Why?
| DNA, Complementary | 1 | 2001 | 145 | 0.050 |
Why?
| Coronary Artery Disease | 1 | 2005 | 329 | 0.050 |
Why?
| Phenotype | 1 | 2004 | 820 | 0.050 |
Why?
| Hepatocytes | 1 | 2001 | 214 | 0.050 |
Why?
| Antioxidants | 1 | 2002 | 297 | 0.050 |
Why?
| Alkanesulfonic Acids | 1 | 1999 | 3 | 0.050 |
Why?
| Hydroxylation | 2 | 1991 | 61 | 0.040 |
Why?
| Morpholines | 1 | 1999 | 64 | 0.040 |
Why?
| Valinomycin | 2 | 1994 | 2 | 0.040 |
Why?
| Membranes, Artificial | 2 | 1994 | 16 | 0.040 |
Why?
| Tissue Distribution | 2 | 2002 | 178 | 0.040 |
Why?
| Formazans | 1 | 1998 | 4 | 0.040 |
Why?
| Pancreas | 2 | 2001 | 80 | 0.040 |
Why?
| Cholagogues and Choleretics | 1 | 1998 | 6 | 0.040 |
Why?
| Receptors, Cholinergic | 1 | 1998 | 16 | 0.040 |
Why?
| Microvilli | 1 | 1998 | 9 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1998 | 47 | 0.040 |
Why?
| DNA Adducts | 1 | 1999 | 162 | 0.040 |
Why?
| Glutamic Acid | 1 | 1999 | 111 | 0.040 |
Why?
| Oxygen | 1 | 2001 | 361 | 0.040 |
Why?
| HEPES | 1 | 1997 | 3 | 0.040 |
Why?
| Reference Values | 2 | 2004 | 354 | 0.040 |
Why?
| Atropine | 3 | 2003 | 31 | 0.040 |
Why?
| Methionine | 1 | 1999 | 146 | 0.040 |
Why?
| Static Electricity | 1 | 1997 | 20 | 0.040 |
Why?
| Solvents | 1 | 1997 | 35 | 0.040 |
Why?
| Benzene Derivatives | 1 | 1997 | 6 | 0.040 |
Why?
| T-Lymphocyte Subsets | 1 | 1997 | 41 | 0.040 |
Why?
| Protein Denaturation | 1 | 1996 | 14 | 0.040 |
Why?
| Ethacrynic Acid | 1 | 1996 | 3 | 0.040 |
Why?
| Caspase 3 | 2 | 2007 | 135 | 0.040 |
Why?
| DNA Damage | 1 | 1999 | 357 | 0.040 |
Why?
| Rats, Inbred F344 | 3 | 1992 | 209 | 0.040 |
Why?
| Diuretics | 1 | 1996 | 28 | 0.040 |
Why?
| Catalase | 1 | 1976 | 74 | 0.040 |
Why?
| Uterus | 1 | 1997 | 98 | 0.040 |
Why?
| Hydrogen-Ion Concentration | 1 | 1996 | 194 | 0.040 |
Why?
| Adaptation, Physiological | 1 | 1976 | 101 | 0.040 |
Why?
| Protein Carbonylation | 1 | 2015 | 7 | 0.030 |
Why?
| Oxygen Consumption | 1 | 1976 | 223 | 0.030 |
Why?
| Fluorescent Antibody Technique | 2 | 2009 | 141 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 1992 | 253 | 0.030 |
Why?
| Saccharomyces cerevisiae | 1 | 1976 | 218 | 0.030 |
Why?
| Chemokine CXCL2 | 1 | 2014 | 14 | 0.030 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 21 | 0.030 |
Why?
| Ethylmaleimide | 1 | 1994 | 4 | 0.030 |
Why?
| Vanadates | 1 | 1994 | 14 | 0.030 |
Why?
| Eye | 1 | 1995 | 36 | 0.030 |
Why?
| Microscopy, Fluorescence | 2 | 2007 | 198 | 0.030 |
Why?
| Oligodeoxyribonucleotides | 1 | 1994 | 30 | 0.030 |
Why?
| Matrix Metalloproteinases | 1 | 2014 | 52 | 0.030 |
Why?
| Diet, High-Fat | 1 | 2016 | 216 | 0.030 |
Why?
| Endothelium, Vascular | 1 | 1996 | 288 | 0.030 |
Why?
| Alanine Transaminase | 1 | 2014 | 151 | 0.030 |
Why?
| Chromatography, Thin Layer | 4 | 2002 | 32 | 0.030 |
Why?
| Drug Resistance | 3 | 2003 | 74 | 0.030 |
Why?
| Daunorubicin | 1 | 1994 | 12 | 0.030 |
Why?
| Actins | 1 | 2014 | 132 | 0.030 |
Why?
| Transcriptome | 1 | 2016 | 346 | 0.030 |
Why?
| Membrane Transport Proteins | 3 | 1999 | 57 | 0.030 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 44 | 0.030 |
Why?
| Antibodies | 1 | 2014 | 178 | 0.030 |
Why?
| Cell Survival | 3 | 2007 | 657 | 0.030 |
Why?
| Fibrosis | 1 | 2014 | 208 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2014 | 158 | 0.030 |
Why?
| Genetic Variation | 3 | 2000 | 253 | 0.030 |
Why?
| Vinblastine | 1 | 1994 | 41 | 0.030 |
Why?
| Muscles | 2 | 1992 | 114 | 0.030 |
Why?
| Perfusion | 2 | 1990 | 40 | 0.030 |
Why?
| Sheep | 1 | 1993 | 88 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 2 | 2003 | 16 | 0.030 |
Why?
| Bilirubin | 1 | 1993 | 49 | 0.030 |
Why?
| Testis | 2 | 2005 | 65 | 0.030 |
Why?
| Leukotrienes | 1 | 1992 | 10 | 0.030 |
Why?
| Radioligand Assay | 2 | 2002 | 49 | 0.030 |
Why?
| Inositol Phosphates | 2 | 2002 | 14 | 0.030 |
Why?
| Rats, Sprague-Dawley | 3 | 2002 | 1663 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 434 | 0.030 |
Why?
| Enzyme Activation | 2 | 2004 | 329 | 0.030 |
Why?
| Affinity Labels | 1 | 1991 | 9 | 0.030 |
Why?
| Uridine Diphosphate Glucuronic Acid | 1 | 1991 | 10 | 0.030 |
Why?
| Molecular Structure | 3 | 2000 | 319 | 0.030 |
Why?
| Rabbits | 2 | 1991 | 425 | 0.030 |
Why?
| Chemistry, Physical | 1 | 1991 | 6 | 0.030 |
Why?
| Chemical Phenomena | 1 | 1991 | 18 | 0.030 |
Why?
| Calcium-Transporting ATPases | 1 | 1991 | 11 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2011 | 49 | 0.030 |
Why?
| Solutions | 1 | 1991 | 29 | 0.030 |
Why?
| Pseudomonas Infections | 1 | 2011 | 54 | 0.030 |
Why?
| Androstenedione | 1 | 1991 | 3 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2011 | 95 | 0.030 |
Why?
| Clofibrate | 1 | 1991 | 7 | 0.030 |
Why?
| Steroid Hydroxylases | 1 | 1991 | 12 | 0.030 |
Why?
| Phenobarbital | 1 | 1991 | 17 | 0.020 |
Why?
| Molecular Conformation | 2 | 2004 | 73 | 0.020 |
Why?
| Cytokines | 1 | 2014 | 676 | 0.020 |
Why?
| Enzyme Induction | 1 | 1991 | 80 | 0.020 |
Why?
| Myocardium | 1 | 1994 | 441 | 0.020 |
Why?
| Bile Ducts | 1 | 1991 | 53 | 0.020 |
Why?
| Sulfurtransferases | 1 | 1990 | 4 | 0.020 |
Why?
| Drug Resistance, Multiple | 2 | 2002 | 20 | 0.020 |
Why?
| Cholic Acid | 1 | 1990 | 1 | 0.020 |
Why?
| Taurocholic Acid | 1 | 1990 | 5 | 0.020 |
Why?
| Carbachol | 2 | 2002 | 33 | 0.020 |
Why?
| Sulfotransferases | 1 | 1990 | 43 | 0.020 |
Why?
| Liver Circulation | 1 | 1990 | 27 | 0.020 |
Why?
| Brain | 2 | 2001 | 1387 | 0.020 |
Why?
| Immunohistochemistry | 2 | 2004 | 1089 | 0.020 |
Why?
| Azides | 2 | 2001 | 9 | 0.020 |
Why?
| Drug Interactions | 2 | 2003 | 206 | 0.020 |
Why?
| Photoaffinity Labels | 2 | 2001 | 15 | 0.020 |
Why?
| Biotinylation | 1 | 2009 | 23 | 0.020 |
Why?
| Glutathione Disulfide | 2 | 2000 | 45 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2011 | 418 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2011 | 746 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 79 | 0.020 |
Why?
| Models, Chemical | 2 | 1999 | 65 | 0.020 |
Why?
| Precipitin Tests | 2 | 2002 | 39 | 0.020 |
Why?
| Dexamethasone | 1 | 1991 | 435 | 0.020 |
Why?
| Cell Line, Tumor | 2 | 2003 | 1550 | 0.020 |
Why?
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 2 | 0.020 |
Why?
| Survival Rate | 1 | 2011 | 951 | 0.020 |
Why?
| Anthracenes | 1 | 2007 | 13 | 0.020 |
Why?
| Caspase 8 | 1 | 2007 | 16 | 0.020 |
Why?
| Case-Control Studies | 1 | 2011 | 1228 | 0.020 |
Why?
| Jurkat Cells | 1 | 2007 | 34 | 0.020 |
Why?
| Co-Repressor Proteins | 1 | 2007 | 17 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2008 | 289 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2007 | 73 | 0.020 |
Why?
| Organ Specificity | 2 | 2001 | 126 | 0.020 |
Why?
| Cytosol | 1 | 2007 | 101 | 0.020 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2007 | 61 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2007 | 64 | 0.020 |
Why?
| Protein Transport | 1 | 2007 | 195 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2007 | 252 | 0.020 |
Why?
| Isoelectric Point | 2 | 1998 | 5 | 0.020 |
Why?
| Cell Transformation, Viral | 1 | 2006 | 27 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2006 | 34 | 0.020 |
Why?
| Lens, Crystalline | 1 | 2006 | 17 | 0.020 |
Why?
| Blood Platelets | 1 | 2009 | 269 | 0.020 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 2005 | 10 | 0.020 |
Why?
| Caspases | 1 | 2006 | 146 | 0.020 |
Why?
| Paraquat | 1 | 2005 | 6 | 0.020 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2005 | 21 | 0.020 |
Why?
| Cytoskeletal Proteins | 1 | 2005 | 58 | 0.020 |
Why?
| Superoxide Dismutase | 1 | 2005 | 125 | 0.020 |
Why?
| NF-E2-Related Factor 2 | 1 | 2005 | 63 | 0.020 |
Why?
| Prospective Studies | 1 | 2011 | 2604 | 0.020 |
Why?
| Insulin-Like Growth Factor I | 1 | 2005 | 137 | 0.020 |
Why?
| Spleen | 1 | 2005 | 186 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2007 | 462 | 0.020 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 42 | 0.020 |
Why?
| Microinjections | 1 | 2004 | 32 | 0.020 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 64 | 0.020 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 67 | 0.020 |
Why?
| Cattle | 2 | 1996 | 224 | 0.020 |
Why?
| Tyrphostins | 1 | 2003 | 16 | 0.010 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 8 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 55 | 0.010 |
Why?
| Quinazolines | 1 | 2003 | 39 | 0.010 |
Why?
| Xanthine Oxidase | 1 | 2003 | 16 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2005 | 656 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 2003 | 56 | 0.010 |
Why?
| Drug Design | 1 | 2004 | 133 | 0.010 |
Why?
| GTP Phosphohydrolases | 1 | 2003 | 35 | 0.010 |
Why?
| Flavonoids | 1 | 2003 | 62 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 151 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2003 | 134 | 0.010 |
Why?
| Trypsin | 1 | 2003 | 17 | 0.010 |
Why?
| Time Factors | 2 | 2003 | 3213 | 0.010 |
Why?
| U937 Cells | 1 | 2003 | 15 | 0.010 |
Why?
| HL-60 Cells | 1 | 2003 | 24 | 0.010 |
Why?
| Inhibitory Concentration 50 | 1 | 2003 | 80 | 0.010 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2003 | 55 | 0.010 |
Why?
| Cross Reactions | 1 | 2003 | 56 | 0.010 |
Why?
| Intracellular Membranes | 1 | 1983 | 26 | 0.010 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2003 | 204 | 0.010 |
Why?
| Cholinesterases | 1 | 2002 | 2 | 0.010 |
Why?
| Computational Biology | 1 | 2004 | 231 | 0.010 |
Why?
| Sex Factors | 1 | 2005 | 767 | 0.010 |
Why?
| Receptor, Muscarinic M3 | 1 | 2002 | 4 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 153 | 0.010 |
Why?
| Selenium | 1 | 2002 | 9 | 0.010 |
Why?
| Cell Cycle | 1 | 2004 | 275 | 0.010 |
Why?
| Insulin | 1 | 2005 | 510 | 0.010 |
Why?
| Glycine | 1 | 2002 | 70 | 0.010 |
Why?
| Hydrolysis | 2 | 1992 | 68 | 0.010 |
Why?
| Endothelial Cells | 1 | 2004 | 294 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 923 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 2001 | 13 | 0.010 |
Why?
| Antibody Specificity | 1 | 2001 | 48 | 0.010 |
Why?
| Phosphorus Radioisotopes | 1 | 2001 | 20 | 0.010 |
Why?
| Haptens | 1 | 2001 | 14 | 0.010 |
Why?
| Sulfuric Acids | 2 | 1991 | 8 | 0.010 |
Why?
| Amino Acid Motifs | 1 | 2001 | 57 | 0.010 |
Why?
| Phenylmethylsulfonyl Fluoride | 1 | 2001 | 1 | 0.010 |
Why?
| ral GTP-Binding Proteins | 1 | 2001 | 3 | 0.010 |
Why?
| Brain Chemistry | 1 | 2001 | 75 | 0.010 |
Why?
| Isomerism | 1 | 2000 | 24 | 0.010 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2003 | 240 | 0.010 |
Why?
| Alkylating Agents | 1 | 2000 | 22 | 0.010 |
Why?
| Intracellular Fluid | 1 | 2000 | 15 | 0.010 |
Why?
| Acrolein | 1 | 2000 | 3 | 0.010 |
Why?
| Cell Adhesion | 1 | 2000 | 171 | 0.010 |
Why?
| Erythropoiesis | 1 | 1999 | 19 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2005 | 1138 | 0.010 |
Why?
| Macromolecular Substances | 1 | 1999 | 47 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1999 | 42 | 0.010 |
Why?
| Dimerization | 1 | 1999 | 59 | 0.010 |
Why?
| Leukotriene C4 | 1 | 1999 | 1 | 0.010 |
Why?
| Osmolar Concentration | 1 | 1999 | 83 | 0.010 |
Why?
| Baculoviridae | 1 | 1998 | 5 | 0.010 |
Why?
| Laryngeal Neoplasms | 1 | 1999 | 55 | 0.010 |
Why?
| Anilino Naphthalenesulfonates | 1 | 1978 | 5 | 0.010 |
Why?
| False Positive Reactions | 1 | 1998 | 68 | 0.010 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 41 | 0.010 |
Why?
| Pepsinogens | 1 | 1998 | 1 | 0.010 |
Why?
| Sincalide | 1 | 1998 | 1 | 0.010 |
Why?
| N-Methylscopolamine | 1 | 1998 | 1 | 0.010 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 3 | 0.010 |
Why?
| Parasympatholytics | 1 | 1998 | 9 | 0.010 |
Why?
| Mass Spectrometry | 2 | 1992 | 313 | 0.010 |
Why?
| Air Pollutants | 1 | 1999 | 70 | 0.010 |
Why?
| Cholecystokinin | 1 | 1998 | 14 | 0.010 |
Why?
| Osmotic Pressure | 1 | 1998 | 11 | 0.010 |
Why?
| Fluoresceins | 1 | 1998 | 16 | 0.010 |
Why?
| Fluorescence | 1 | 1978 | 53 | 0.010 |
Why?
| Cell Count | 1 | 1998 | 181 | 0.010 |
Why?
| Caco-2 Cells | 1 | 1998 | 50 | 0.010 |
Why?
| Spectrometry, Fluorescence | 1 | 1998 | 53 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 562 | 0.010 |
Why?
| Amino Acids | 1 | 2000 | 369 | 0.010 |
Why?
| Pregnancy | 2 | 1997 | 2620 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 1998 | 116 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1997 | 82 | 0.010 |
Why?
| Temperature | 1 | 1998 | 177 | 0.010 |
Why?
| Benzo(a)pyrene | 1 | 1997 | 38 | 0.010 |
Why?
| Enzyme Precursors | 1 | 1976 | 6 | 0.010 |
Why?
| Cell Differentiation | 1 | 1999 | 720 | 0.010 |
Why?
| Drug Screening Assays, Antitumor | 1 | 1996 | 142 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 1997 | 233 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 1999 | 570 | 0.010 |
Why?
| Carcinoma, Squamous Cell | 1 | 1999 | 384 | 0.010 |
Why?
| Algorithms | 1 | 1999 | 697 | 0.010 |
Why?
| Consensus Sequence | 1 | 1994 | 25 | 0.010 |
Why?
| Sequence Alignment | 1 | 1994 | 146 | 0.010 |
Why?
| Adult | 3 | 2001 | 14207 | 0.010 |
Why?
| Chickens | 1 | 1994 | 118 | 0.010 |
Why?
| Placenta | 1 | 1994 | 135 | 0.010 |
Why?
| Esterification | 1 | 1992 | 6 | 0.010 |
Why?
| Metals | 1 | 1992 | 44 | 0.010 |
Why?
| Acetylation | 1 | 1992 | 99 | 0.010 |
Why?
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 1991 | 1 | 0.010 |
Why?
| Methylation | 1 | 1992 | 130 | 0.010 |
Why?
| Photochemistry | 1 | 1991 | 21 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 1978 | 820 | 0.010 |
Why?
| Ligation | 1 | 1991 | 64 | 0.010 |
Why?
| Calcimycin | 1 | 1989 | 6 | 0.010 |
Why?
| Neoplasms | 1 | 2000 | 1316 | 0.010 |
Why?
| Cell Separation | 1 | 1989 | 107 | 0.010 |
Why?
| Chromatography, Gas | 1 | 1986 | 16 | 0.000 |
Why?
| Aged | 2 | 1990 | 10054 | 0.000 |
Why?
| Diacylglycerol Cholinephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| Ethanolaminephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| Centrifugation, Density Gradient | 1 | 1980 | 26 | 0.000 |
Why?
| Microsomes | 1 | 1980 | 45 | 0.000 |
Why?
| Muscle Development | 1 | 1980 | 25 | 0.000 |
Why?
| Adolescent | 1 | 1990 | 6897 | 0.000 |
Why?
| Child, Preschool | 1 | 1987 | 4147 | 0.000 |
Why?
| Child | 1 | 1990 | 7341 | 0.000 |
Why?
| Middle Aged | 1 | 1990 | 13088 | 0.000 |
Why?
|
|
Zimniak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|